BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38509467)

  • 1. Implementation and external validation of the Cambridge Multimorbidity Score in the UK Biobank cohort.
    Harrison H; Ip S; Renzi C; Li Y; Barclay M; Usher-Smith J; Lyratzopoulos G; Wood A; Antoniou AC
    BMC Med Res Methodol; 2024 Mar; 24(1):71. PubMed ID: 38509467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between multimorbidity and adverse health outcomes in UK Biobank and the SAIL Databank: A comparison of longitudinal cohort studies.
    Hanlon P; Jani BD; Nicholl B; Lewsey J; McAllister DA; Mair FS
    PLoS Med; 2022 Mar; 19(3):e1003931. PubMed ID: 35255092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimorbidity in a selected cohort compared to a representative sample: Does selection bias influence outcomes?
    Hanlon P; Bhautesh J; Mair F; McAllister D
    Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of multimorbidity and their effects on adverse outcomes in rheumatoid arthritis: a study of 5658 UK Biobank participants.
    McQueenie R; Nicholl BI; Jani BD; Canning J; Macdonald S; McCowan C; Neary J; Browne S; Mair FS; Siebert S
    BMJ Open; 2020 Nov; 10(11):e038829. PubMed ID: 33234629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts.
    Chiang JI; Hanlon P; Li TC; Jani BD; Manski-Nankervis JA; Furler J; Lin CC; Yang SY; Nicholl BI; Thuraisingam S; Mair FS
    PLoS Med; 2020 May; 17(5):e1003094. PubMed ID: 32379755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between risk, duration and cause of hospitalisations in people with rheumatoid arthritis and multimorbidity in the UK Biobank and Scottish Early Rheumatoid Arthritis (SERA) cohorts: Longitudinal observational study.
    Morton FR; Jani BD; Mair FS; McLoone P; Canning J; Macdonald S; McQueenie R; Siebert S; Nicholl BI
    Semin Arthritis Rheum; 2023 Feb; 58():152130. PubMed ID: 36459724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of the Cambridge Multimorbidity Score.
    Payne RA; Mendonca SC; Elliott MN; Saunders CL; Edwards DA; Marshall M; Roland M
    CMAJ; 2020 Feb; 192(5):E107-E114. PubMed ID: 32015079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypes and rates of cancer-relevant symptoms and tests in the year before cancer diagnosis in UK Biobank and CPRD Gold.
    Barclay M; Renzi C; Antoniou A; Denaxas S; Harrison H; Ip S; Pashayan N; Torralbo A; Usher-Smith J; Wood A; Lyratzopoulos G
    PLOS Digit Health; 2023 Dec; 2(12):e0000383. PubMed ID: 38100737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
    Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
    Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthy lifestyle and life expectancy in people with multimorbidity in the UK Biobank: A longitudinal cohort study.
    Chudasama YV; Khunti K; Gillies CL; Dhalwani NN; Davies MJ; Yates T; Zaccardi F
    PLoS Med; 2020 Sep; 17(9):e1003332. PubMed ID: 32960883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a modified Cambridge Multimorbidity Score for use with SNOMED CT: an observational English primary care sentinel network study.
    Tsang RS; Joy M; Whitaker H; Sheppard JP; Williams J; Sherlock J; Mayor N; Meza-Torres B; Button E; Williams AJ; Kar D; Delanerolle G; McManus R; Hobbs FR; de Lusignan S
    Br J Gen Pract; 2023 Jun; 73(731):e435-e442. PubMed ID: 37130611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data-driven patient stratification of UK Biobank cohort suggests five endotypes of multimorbidity.
    Prasad B; Bjourson AJ; Shukla P
    Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36209412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants.
    Hanlon P; Nicholl BI; Jani BD; Lee D; McQueenie R; Mair FS
    Lancet Public Health; 2018 Jul; 3(7):e323-e332. PubMed ID: 29908859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5 year mortality predictors in 498,103 UK Biobank participants: a prospective population-based study.
    Ganna A; Ingelsson E
    Lancet; 2015 Aug; 386(9993):533-40. PubMed ID: 26049253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort.
    Jani BD; Hanlon P; Nicholl BI; McQueenie R; Gallacher KI; Lee D; Mair FS
    BMC Med; 2019 Apr; 17(1):74. PubMed ID: 30967141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia, long-term conditions, and multimorbidity: findings from UK Biobank participants.
    Dodds RM; Granic A; Robinson SM; Sayer AA
    J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):62-68. PubMed ID: 31886632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort.
    McQueenie R; Foster HME; Jani BD; Katikireddi SV; Sattar N; Pell JP; Ho FK; Niedzwiedz CL; Hastie CE; Anderson J; Mark PB; Sullivan M; O'Donnell CA; Mair FS; Nicholl BI
    PLoS One; 2020; 15(8):e0238091. PubMed ID: 32817712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple approaches to characterising multiple long-term conditions (multimorbidity) and rates of emergency hospital admission: Findings from 495,465 UK Biobank participants.
    Dodds RM; Bunn JG; Hillman SJ; Granic A; Murray J; Witham MD; Robinson SM; Cooper R; Sayer AA
    J Intern Med; 2023 Jan; 293(1):100-109. PubMed ID: 36131375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Physical Activity Intensity on the Dynamic Progression of Cardiometabolic Multimorbidity: Prospective Cohort Study Using UK Biobank Data.
    Liu BP; Zhu JH; Wan LP; Zhao ZY; Wang X; Jia CX
    JMIR Public Health Surveill; 2023 Sep; 9():e46991. PubMed ID: 37747776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a dementia risk score in the UK Biobank and Whitehall II cohorts.
    Anatürk M; Patel R; Ebmeier KP; Georgiopoulos G; Newby D; Topiwala A; de Lange AG; Cole JH; Jansen MG; Singh-Manoux A; Kivimäki M; Suri S
    BMJ Ment Health; 2023 Jul; 26(1):. PubMed ID: 37603383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.